XTL Biopharmaceuticals Ltd ADR (XTLB) — Financial Flexibility Index
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Financial Flexibility Index of -10.73x as of December 2022. Free cash flow of $-2.01 Million (operating CF $-2.01 Million minus capex $0.00) represents -11% of total liabilities ($187.00K). Check XTL Biopharmaceuticals Ltd ADR (XTLB) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
XTL Biopharmaceuticals Ltd ADR Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for XTL Biopharmaceuticals Ltd ADR across 22 annual periods. For the full cash flow conversion analysis, see XTL Biopharmaceuticals Ltd ADR cash conversion from operations.
Annual Financial Flexibility Index for XTL Biopharmaceuticals Ltd ADR (2003–2024)
Year-by-year free cash flow to debt coverage for XTL Biopharmaceuticals Ltd ADR. Explore XTLB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.50x | $-1.56 Million | $-1.62 Million | $3.12 Million | ▲ +85.4% |
| 2023 | -3.43x | $-707.00K | $-707.00K | $206.00K | ▲ +28.8% |
| 2022 | -4.82x | $-901.00K | $-901.00K | $187.00K | ▼ -490.2% |
| 2021 | -0.82x | $-1.05 Million | $-1.05 Million | $1.28 Million | ▲ +75.6% |
| 2020 | -3.34x | $-849.00K | $-850.00K | $254.00K | ▲ +14.4% |
| 2019 | -3.91x | $-906.00K | $-908.00K | $232.00K | ▼ -21.4% |
| 2018 | -3.22x | $-814.00K | $-816.00K | $253.00K | ▼ -750.0% |
| 2017 | -0.38x | $-1.12 Million | $-1.12 Million | $2.97 Million | ▲ +92.5% |
| 2016 | -5.05x | $-1.67 Million | $-1.73 Million | $330.00K | ▼ -22.6% |
| 2015 | -4.12x | $-1.79 Million | $-1.86 Million | $436.00K | ▼ -61.5% |
| 2014 | -2.55x | $-2.46 Million | $-2.47 Million | $965.00K | ▼ -29.8% |
| 2013 | -1.96x | $-2.42 Million | $-2.50 Million | $1.23 Million | ▼ -129.8% |
| 2012 | -0.85x | $-1.42 Million | $-1.51 Million | $1.66 Million | ▲ +70.0% |
| 2011 | -2.84x | $-1.79 Million | $-1.80 Million | $629.00K | ▼ -280.9% |
| 2010 | -0.75x | $-719.00K | $-735.00K | $963.00K | ▲ +78.8% |
| 2009 | -3.51x | $-2.49 Million | $-2.49 Million | $708.00K | ▲ +33.4% |
| 2008 | -5.28x | $-10.58 Million | $-10.58 Million | $2.00 Million | ▼ -37.2% |
| 2007 | -3.85x | $-21.39 Million | $-21.46 Million | $5.56 Million | ▼ -26.7% |
| 2006 | -3.04x | $-12.57 Million | $-12.59 Million | $4.14 Million | ▼ -13.5% |
| 2005 | -2.67x | $-10.43 Million | $-10.47 Million | $3.90 Million | ▼ -12.5% |
| 2004 | -2.38x | $-14.31 Million | $-14.49 Million | $6.02 Million | ▲ +23.8% |
| 2003 | -3.12x | $-13.24 Million | $-13.33 Million | $4.25 Million | — |